Physician Patient

35th Annual Door County Summer Institute


After two years of a pandemic pause for in-person sessions, we hope this year’s offerings will return you to Door County and assist you in your ongoing professional development while providing an opportunity to recharge and reinvigorate yourself.

For now, we will still plan on social distancing and expect attendees to wear masks throughout each session. We also will require proof of vaccination and booster(s) to attend.

Due to our late start, we have limited the number of sessions. From July 25 to August 12, 2022, 8 separate sessions will comprise this year’s Summer Institute. The 5-day sessions are held from 9 a.m. to 12:15 p.m., and 2-day sessions from 8 a.m. to 12:15 p.m., leaving afternoons free to explore the wonders of Door County. All seminars are held at the Landmark Resort in Egg Harbor, WI. (By the way, Dr. Russell Barkley has informed us that he intends to retire from the lecture circuit after this summer’s Institute.)

We look forward to seeing you in person again.

Carlyle Chan, MD
Director and Founder,
Door County Summer Institute

Psychiatry Door County Summer Institute

Tuition Information

  • Tuition for 5-day sessions is $675. Two-day sessions are $375.
  • Tuition for 5-day sessions will be reduced to $630, and to $350 for 2-day sessions, if received by June 1, 2022.

Further registration details coming soon.

View the 2022 Institute Schedule (PDF)

Register now

Session Information

From July 25 to August 12, 2022, 8 separate sessions will comprise this year’s Summer Institute. The 5-day sessions are held from 9 a.m. to 12:15 p.m., and 2-day sessions from 8 a.m. to 12:15 p.m., leaving afternoons free to explore the wonders of Door County. All seminars are held at the Landmark Resort in Egg Harbor, WI. A continental breakfast will be served daily. Casual dress is standard for all sessions.

Register Now

Special Needs

Please call our office at (414) 955-7250 at least two weeks in advance of any session if you have special needs.

Session 1 (5 Days) | July 25–29, 2022 | 9 a.m.-12:15 p.m.

Donald Meichenbaum, PhD
Bolstering Resilience in the Aftermath of the COVID-19 Pandemic

Donald Meichenbaum, PhD, is Distinguished Professor Emeritus, University of Waterloo, Ontario, Canada. He is Research Director of the Melissa Institute for Violence Prevention in Miami. He is one of the founders of cognitive behavior therapy, and in a survey of clinicians, he was voted "one of the ten most influential psychotherapists of the 20th century." This workshop provides Dr. Meichenbaum an opportunity to share his clinical experience and research of over a 50-year career working with clients and treatment centers covering the entire lifespan. He has published extensively, and his recent books include Roadmap to Resilience, Treating Individuals with Addictive Disorders, and the Evolution of Cognitive-Behavior Therapy.

Course Description

The worldwide impact of the COVID-19 pandemic has been tragic in terms of the loss of lives, economic setbacks, disruptive lifestyles, and ongoing uncertainty. Moreover, the war in Ukraine has resulted in further despair and demoralization. These events have contributed to a wide array of emotional and behavioral disorders such as anxiety, depression with accompanying increases in suicides, a rise in substance abuse disorders and accompanying interpersonal violence. Mental health professionals have been challenged to use telehealth interventions, as well as bolster their own resilience.

While most individuals, families and communities evidence an impact of the various pandemic stressors, the research indicates that some 75% will go onto develop resilience and deal with ongoing adversities, while some 25% will develop some forms of adjustment challenges and various forms of PTSD and co-occurring disorders.

This workshop highlights what distinguishes these two groups and considers the treatment implications across the entire lifespan, from "high-risk" children and their families to the elderly. TRAUMA IS EVERYWHERE, BUT SO IS RESILIENCE. Specific ways therapists bolster resilience in individuals, couples, families, and communities will be the focus of this workshop. How to use evidenced-based cognitive behavioral and Constructive Narrative strength-based interventions to bolster will be discussed.

A second focus is what is behind the research findings that 25% of therapists obtain 50% better treatment outcomes and they have 50% fewer patient dropouts from treatment? Namely, what are the Core tasks of therapy that these "expert" therapists are doing that bolsters their patients' resilience?

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Enumerate the Core tasks of psychotherapy that reflects expertise
  • Be able to discuss ways to bolster resilience in six domains (physical. interpersonal, emotional, cognitive behavioral and spiritual)
  • Implement ways to bolster resilience in children, adolescents, adults, and the elderly
  • Appreciate how to bolster resilience in themselves
  • Discuss the treatment of patients who experience a variety of disorders including PTSD, anxiety, depression, suicidal behaviors, and grief disorders
  • Plan how to achieve long lasting behavioral changes in patients

Monday, July 25

  • The impact of the COVID-19 pandemic
  • Trauma is everywhere, but so is resilience
  • The nature of "expertise“: Implications for conducting therapeutic interventions
  • Core tasks of psychotherapy

Tuesday, July 26

  • Ways of bolstering resilience in adults
  • What distinguishes individuals who evidence resilience VERSUS those who get "stuck"
  • How to help adults develop a "resilient mindset“: Constructive Narrative interventions
  • An illustrative example: Treatment of individuals with Prolonged and Complicated Grief Disorders

Wednesday, July 27

  • Ways to treat patients with anxiety, depression, and suicidality
  • Ways to bolster resilience in couples, families, and communities

Thursday, July 28

  • Ways to bolster resilience in "high risk" children and their families
  • What can schools, clinicians, and communities do to bolster resilience?
  • Ways to bolster resilience in adolescents

Friday, July 29

  • Ways to bolster resilience in "high risk" children and their families
  • What can schools, clinicians and communities do to bolster resilience?
  • Ways to bolster resilience in adolescents
Session 2 (5 Days) | July 25–29, 2022 | 9 a.m.-12:15 p.m.

Phil Janicak, MD
Update on Psychopharmacotherapy and Therapeutic Neuromodulation

Phil Janicak, MD, is an Adjunct Professor and Consultant to the Therapeutic Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, and a Distinguished Life Fellow in the American Psychiatric Association. He was a Professor of Psychiatry and Pharmacology, the Medical Director of the Psychiatric Clinical Research Center, and the Associate Program Director for the NIH General Clinical Research Center at the University of Illinois Medical Center from 1994-2004. He then became a Professor of Psychiatry at Rush University and was the Director of the Rush Psychiatric Clinical Research and Transcranial Magnetic Stimulation Centers from 2004-2014. He developed and directed the TMS Center at Linden Oaks Medical Group from 2014-2017.

Dr. Janicak’s primary research interests are in the assessment and treatment of mood and psychotic disorders. In this context, he has conducted over 60 clinical trials. He has been an NIMH grant awardee as both a principal and co-investigator. He has authored, co-authored, or edited over 500 publications in the psychiatric literature and is first author of the Principles and Practice of Psychopharmacotherapy.

Dr. Janicak was the editor of the Psychopharm Review from 2004-2014 and presently serves on the Editorial Board of Current Psychiatry. He has also been a reviewer for several journals, including: The American Journal of Psychiatry, Biological Psychiatry, JAMA Psychiatry, Journal of the American Medical Association, Journal of ECT, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, Psychiatric Annals, Psychiatry Research and Schizophrenia Research.

Course Description

This course will use evidence-based and measurement-based care to develop optimal treatment approaches for the major psychiatric disorders. This is in the context of insufficient response to standard interventions (e.g. antipsychotics for schizophrenia). Course participants will be able to develop specific treatment strategies based on randomized controlled and pragmatic trial data tempered by the realities of clinical practice (i.e. every patient is a study of n=1). This will include consideration of relevant issues such as pharmacokinetics, pharmacodynamics, and drug interactions.

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Better appreciate the role of evidence-based and measurement-based care to optimize treatment outcomes
  • Consider the relative value of various psychotropics for specific disorders
  • Recognize the emerging role of translational psychiatry in addressing the shortcomings of existing therapies
  • Understand the importance of developing strategies which will enhance patient adherence to treatment

Monday, July 25
Introduction and Psychosis

Tuesday, July 26

Wednesday, July 27

Thursday, July 28
Bipolar disorder

Friday, July 29
Anxiety-related Disorders

Session 3 (5 Days) | August 1–5, 2022 | 9  a.m.-12:15 p.m.

Fred Heide PhD and Lee Becker
Medical Improvisation 101

Frederick J. Heide, PhD, is Adjunct Professor at the California School of Professional Psychology at Alliant International University in the San Francisco Bay Area. There he was a member of the core faculty for 37 years and won both the Master Teacher and Teacher of the Year Awards. He earned his doctorate in clinical psychology from Pennsylvania State University in 1981 and has presented at MCW’s Door County Summer Institute for 23 continuous seasons. Dr. Heide received the Outstanding Research Contribution Award from the Association for Advancement of Behavior Therapy (AABT) for his foundational work on relaxation-induced anxiety and has published in the Journal of Consulting and Clinical Psychology, Psychophysiology, Mindfulness, Journal of Psychotherapy Integration, Behavior Research and Therapy, Psychology of Aesthetics, Creativity and the Arts, Psychotherapy: Theory, Research, Practice, Training, Journal of Psychoactive Drugs, and elsewhere. He also served as associate editor of the APA journal PsycCRITIQUES. Dr. Heide co-founded and has performed for almost five decades with Door County’s Northern Sky Theater, which has received the Wisconsin Governor’s Award for Arts, Culture and Heritage. He has recorded three albums and co-authored 20 shows including Packer Fans from Outer Space and Belgians in Heaven (both with Lee Becker and James Kaplan), as well as the deer-hunting musical Guys & Does (with Lee Becker and Paul Libman). Dr. Heide also co-created several shows with Second City’s founding director Paul Sills, including Moon of the Long Nights, Tales of the Midnight Sun, and Ya Ya You Betcha.

Lee Becker began improvising over 30 years ago with ComedySportz while attending UW-Madison. He helped found ComedySportz NYC, and also worked with the group in Milwaukee, running workshops in all three locations. He is a core member of Northern Sky Theater where he is a performer, musician, and playwright. Lee was a founding member of Door Shakespeare and has also performed and written for First Stage Children’s Theater in Milwaukee.

Course Description

It has long been recognized that the practice of physical and mental health care involves adaptation to unexpected challenges. Recently a new movement spearheaded at Northwestern University’s Feinberg School of Medicine has begun using improvisational acting exercises to teach physicians, psychotherapists, nurses, and pharmacists the ability to respond flexibly in the face of change. Medical improvisation has shown promise in promoting a wide variety of additional communication skills, including empathy, mindfulness, affirmation, collaboration, and authenticity. While the effects of practicing medical improv can often be humorous, participants do not need to be “funny” to do it. The leaders of this largely experiential workshop will draw on their close collaboration with Paul Sills, founding director of Chicago’s Second City, who used improvisation to train renowned actors such as Alan Arkin and Alan Alda. After an overview of current research and theory in medical improvisation, the bulk of the week will be devoted to engaging in and discussing a series of simple and entertaining improv exercises in a safe, highly supportive atmosphere. No previous experience with improvisation is required.

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Learn about literature documenting the importance of spontaneity and improvisational ability in medicine, psychotherapy, pharmacy, and other health-related fields
  • Understand Fu’s (2019) classification of medical improvisation’s goals and core skills into three categories: (a). Attunement (knowledge of self and others), (b). Affirmation (validation of self and others), and (c). Advancement (enrichment of self and others)
  • Review research demonstrating the importance of patient-centered communication in improving clinical outcomes, reducing malpractice suits, and enhancing patient satisfaction
  • Practice micro-communication skills via medical improvisation, including mindfulness, empathy, agreement, adaptation to feedback, comfort with failure, etc.

Monday, August 1
What is medical improvisation? Definitions; The critical role of spontaneous adaptability in health care; Overview of Fu’s (2019) classification of the goals and benefits of medical improvisation; Literature documenting the critical role of provider-patient communication in improving outcomes and increasing patient satisfaction; Evidence for the effectiveness of medical improvisation in improving provider flexibility, confidence, and collaboration; Basic principles of medical improvisation; Warm-up exercises

Tuesday, August 2
Medical Improvisation 1

Wednesday, August 3
Medical Improvisation 2

Thursday, August 4
Medical Improvisation 3

Friday, August 5
Summary and conclusions; Wrap-up exercises

Session 4 (2 Days) | August 1–2, 2022 | 8 a.m.-12:15 p.m.

Benjamin Brett, PhD & Alissa Butts PhD
Neuropsychology: Memory and TBI

Dr. Benjamin Brett, is a clinical neuropsychologist and Assistant Professor in the Department of Neurosurgery at the Medical College of Wisconsin. As a Center for Neurotrauma Research faculty member, Dr. Brett is an active researcher and co-investigator on several multicenter studies examining acute and chronic effects of sport-related concussion/traumatic brain injury. In this role, he has received grant funding from the National Institute on Aging of the National Institutes of Health to examine the long-term effects of sport-related concussion across the lifespan. He is the author of 58 peer-reviewed publications and four book chapters. Dr. Brett also currently performs clinical work as a neuropsychologist in various settings at the Medical College of Wisconsin, including the traumatic brain injury clinic. Additionally, he currently holds committee membership positions with multiple national organizations, including the American Academy of Clinical Neuropsychology and Sports Neuropsychology Society.

Alissa M. Butts, PhD, ABPP-CN is an Assistant Professor of Neurology and is board certified in Clinical Neuropsychology (American Board of Professional Psychology) at the Medical College of Wisconsin. She completed her fellowship at the Mayo Clinic and was Faculty there until 2019 when she joined the faculty at MCW. Dr. Butts specializes in the assessment of adults with cognitive deficits associated with a variety of neurologic and other medical conditions, with particular interest in neurodegenerative disorders. She was involved with the Healthy Actions to Benefit Independence and Thinking (HABIT)® program for individuals with Mild Cognitive Impairment (MCI) while at the Mayo Clinic and is currently heavily involved in the Interdisciplinary Memory Assessment Program (IMAP) at MCW for individuals undergoing workup for dementia. Dr. Butts’ research interests include neurocognitive and neuroimaging correlates of neurodegenerative syndromes, including typical and atypical presentations of Alzheimer’s disease and related dementias. She continues to hold an External Research Collaborator position with Mayo Clinic, and she has been primary or co-author on many papers on neurodegenerative disorders.

Course Descriptions

Monday, August 1
Traumatic brain injury: Clinical classification/presentation, recovery, and subacute- to long-term outcomes

Traumatic brain injury (TBI) is a significant domestic and international public health problem. Clinically, TBI can result in diverse sets of presentations (i.e., various signs and symptoms) and outcomes, which can present challenges in diagnosis and injury management. This workshop will review the fundamental landscape of TBI, including common mechanisms of injury, conventional definitions/classifications, biological and clinical sequelae, typical and atypical recovery, and the role of neuropsychological assessment in diagnosis and injury management. Estimates suggest that 70-90 percent of all traumatic brain injuries are mild in severity based on traditional sets of classification criteria. A recent report from the National Academies of Science, Engineering, and Medicine concluded that a more refined approach to injury severity taxonomy beyond the traditional classification system of ‘mild, moderate, and severe was necessary.’ Further, growing evidence suggests that there is a spectrum of injury severity within the ‘mild’ TBI classification category. This program will review the gradient of injury characteristics, clinical presentation, and biological markers (neuroimaging and blood-based biomarkers) along this ‘mild’ injury severity spectrum. Finally, there is increasing awareness and concern around TBI, sport-related concussion, and repetitive head impact exposure (via contact sport participation) as a risk factor for Alzheimer’s disease and related dementias (ADRDs). This program will review the current evidence for TBI, sport-related concussion, and contact sport exposure as a risk factor for ADRDs, as well as moderating factors throughout the lifespan that may attenuate or intensify these associations.

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Classify TBI injury severity based on acute injury characteristics and apply this classification to their understanding of patient recovery and prognosis.
  • Familiarize with common post-injury sequelae and conventional methods of assessment.
  • Differentiate various injury-related features (e.g., neuroimaging, symptom severity, recovery) across the severity spectrum within the ‘mild’ traumatic brain injury classification.
  • Understand the risk of adverse long-term outcomes (clinical syndromes, clinical function, and neurobiological) associated with TBI, sport-related concussion, and contact sport exposure, as well as factors that may moderate these associations.

Tuesday, August 2
Normal Aging to Dementia: Neuropsychological Patterns and Contributions to Common Diagnoses and Strategies for Healthy Aging

This session will review cognition through normal aging, mild cognitive impairment, and dementia in the elderly. Common neurodegenerative dementia syndromes, such as Alzheimer’s disease and frontotemporal dementia, will also be discussed including the cognitive profiles and associated behavioral changes. Finally, we will review strategies for brain health and wellness to help prevent or delay the onset of cognitive decline.

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Discuss the differences between normal aging, Mild Cognitive Impairment, and Dementia
  • Learn about common neurodegenerative syndromes
  • Recognize the neuropsychological patterns that often emerge
  • Identify at least 2 strategies for brain health and wellness
Session 5 (2 Days) | August 4–5, 2022 | 8 a.m.-12:15 p.m.

Russell A. Barkley, PhD
Clinical Update on ADHD Across the Lifespan

Russell A. Barkley, PhD, is a clinical neuropsychologist and is retired from his previous position as Clinical Professor of Psychiatry at the Virginia Commonwealth University School of Medicine, Richmond, VA. He has previously worked as an Associate Professor of Neurology and Psychiatry at the Medical College of Wisconsin (1977-1985), then as Professor of Psychiatry and Neurology at the University of Massachusetts Medical Center (1985-2002), after which he was Professor of Psychiatry and Health Professions at the Medical University of South Carolina (2003-2017). He is a Diplomate (board certified) in three specialties, Clinical Psychology (ABPP), Clinical Child and Adolescent Psychology, and Clinical Neuropsychology (ABCN, ABPP). Dr. Barkley is a clinical scientist, educator, and practitioner who has published 26 books, rating scales, and clinical manuals numbering 44 editions. He has also published more than 300 scientific articles and book chapters related to the nature, assessment, and treatment of ADHD and related disorders. He is the founder and Editor of the bimonthly clinical newsletter, The ADHD Report, now in its 30th and final year of publication. Dr. Barkley has presented more than 800 invited addresses internationally across more than 30 countries and appeared on nationally televised programs such as 60 Minutes, the Today Show, Good Morning America, CBS Sunday Morning, CNN, and many other programs on behalf of those with ADHD. He has received awards from professional societies and ADHD organizations for his lifetime achievements, career accomplishments, and contributions to research in ADHD, to clinical practice, and for the dissemination of science.

Course Description

This is planned to be the last workshop that Dr. Barkley will provide in his career as he has now retired from his professional activities. In this two-day (8 hour) program, he will provide an in-depth look at major advances in five clinically important topics pertaining to child and adult ADHD. Each of the five lecture topics provides a “deep dive” into what is currently known in these topics and their implications for the diagnosis and management of ADHD.

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Understand the nature of ADHD from the perspective of executive functioning and discuss the five major executive functions and their deficits in people with ADHD, including working memory, self-management to time, emotional self-regulation, self-motivation, and other aspects of executive functioning and self-control.
  • Develop a better understanding of how this theory leads to more effectively designed interventions for those with the disorder.
  • Review in detail the best management principles to teach parents in more effectively managing their child or teen’s ADHD and its related deficits in self-regulation and executive functioning, as well as additional recommendations for dealing with children with ADHD during the COVID-19 pandemic and associated requirements for sheltering in place.
  • Recognize the primary characteristics of ADHD in adults and the issues involved in evaluating ADHD in adults and become familiar with various evidence-based treatments.

Thursday, August 4
Focus on Child ADHD

Lecture #1: An Update on the Executive Functioning-Self-Regulation Theory of ADHD: Implications for Management

Dr. Barkley has developed one of the leading theories of executive functioning and its role in the nature of ADHD. This theory is based on understanding the nature of the executive neuropsychological functions as a multi-level meta-construct and its contribution to self-regulation across time to support the individual’s long-term goals and general welfare. This model views EF not just as a suite of purely cognitive capacities but as an extended phenotype from brain functioning into ever widening spheres of daily adaptive, self-reliant, and cooperative social functioning across the major domains of daily life activities in which humans must function effectively to survive and prosper. From this theory, he has developed numerous clinical implications concerning the diagnosis, assessment, and management of ADHD. Specific management principles will be developed from the theory that extends across multiple domains of major life activities.

Lecture #2: Counseling Parents: The 14 Best Principles for Managing Executive Functioning Deficits in Children and Teens with ADHD

This presentation is a follow-up to lecture #1 in providing a detailed review of the 14 most effective principles for parents to adopt in understanding and raising a child or teen with ADHD. These principles are largely based on Dr. Barkley’s theory of ADHD as a disorder of self-regulation and executive functioning.

Lecture #3: Health Outcomes of Childhood ADHD by Adulthood: Implications for Life Expectancy and Clinical Management

That childhood ADHD predisposes to increased risks for impairment in educational, family, peer, and eventual occupational functioning by young adulthood, among many other major domains of life activities is well established in research. Less appreciated is that the disorder also predisposes to increased health, medical, and dental risks, such as an increased risk for accidental injuries as well as suicide across the lifespan. But ADHD also predisposes to certain personality traits and lifestyle choices that have a significant impact on these health-related factors. Such risks and impairments are known to influence estimated life expectancy. This lecture describes the various health and lifestyle domains of major life activities that have been found to be significantly impaired in children growing up with ADHD by their young adult years. It will show that ADHD adversely affects health outcomes and that such outcomes may have a substantial detrimental impact on estimated life expectancy by young adulthood. The implications of these findings for alterations in ADHD management will also be discussed.

Friday, August 5
Focus on Adult ADHD

ADHD is now recognized as a relatively common mental disorder of adults, affecting 4-5 percent of the adult population and accounting for an increasing number of referrals to mental health and family practices in this country. The disorder has a pervasive impact on most major domains of daily life activities, including occupational, educational, and social functioning and health-related behavior. It is therefore imperative that mental health, medical, and adult educational professionals have as much up-to-date knowledge of this adult disorder and its treatment as possible.

This 4-hour program will provide current information on the nature of ADHD in adults and diagnostic issues, the most likely comorbid disorders associated with it, and the adaptive impairments likely to occur in adults with ADHD. Dr. Barkley will provide guidance on the issues involved in the assessment of ADHD in adults. He will also describe the most effective treatment strategies for managing adult ADHD, highlighting counseling, medications, cognitive-behavioral therapy for executive function deficits, and educational and workplace accommodations.

NOTE: We anticipate a video recorded web-based rebroadcast of Dr. Barkley’s presentations at a later date with a separate registration. Details forthcoming.

Session 6 (5 Days) | August 8–12, 2022 | 9 a.m.-12:15 p.m.

Francis G. Lu, MD, DLFAPA
Enhancing Compassion as a Means to Resilient Well-Being through the Mindful Viewing of Films

Francis G. Lu, MD, is the Luke & Grace Kim Professor in Cultural Psychiatry, Emeritus, at the University of California, Davis. As a Distinguished Life Fellow of the American Psychiatric Association (APA), Dr. Lu has contributed to the areas of cultural psychiatry, psychiatric education, film and psychiatry, and psychiatry/religion/spirituality. In 2008, the Association for Academic Psychiatry awarded him its Lifetime Achievement in Education Award. The APA awarded him a Distinguished Service Award in 2020 as well as the American College of Psychiatrists in 2021. In 2020, the Society for the Study of Psychiatry and Culture awarded him the Lifetime Achievement Award. Since 1987, he has led/co-led 36 film seminars at Esalen Institute, Big Sur, CA. Since 2013, he has led 7 film seminars at DCSI.

Course Description

“Although the world is full of suffering, it is also full of the overcoming of it.” – Helen Keller

Compassion has been defined by Paul Gilbert as “a sensitivity to suffering in self and others with a commitment to try to alleviate and prevent it.” Further, the Dalai Lama has observed, “Only the development of compassion and understanding for others can bring us the tranquility and happiness we all seek.” Clinician well-being is essential for safe, high-quality patient care. This seminar aims at a mindfulness experience through viewing 5 feature films from the U.S., Mexico, Japan, and Germany in which inspiring characters embody compassion as a way to resilient well-being for the purpose of renewing these qualities in the lives of the seminar participants and in our work with patients. On each of the 5 mornings, 1 film is shown via Blu-ray video projection and 6 loudspeakers with an introduction and centering process to begin the session and processing after the film focusing on the participant's own experience of the movie including silent reflection, journaling, dyadic sharing, and group discussion. Supplementary optional films (non-CME) will be shown on 2 evenings. Films take on an exquisite cumulative power when shown over 5 days at the DCSI in a group setting that is truly remarkable and unforgettable.

Leaning Objectives

Participants who engage in this education intervention will be able to:

  • Identify how film characters embody compassion as a way to resilient well-being so as to identify these strengths in themselves and in their patients.
  • Develop skills and practice techniques of viewing of films from a mindfulness perspective in which inspiring characters embody compassion as a means to resilient well-being for the purpose of renewing these qualities in their lives.
  • Understand the essential role of developing compassion as a way to resilient well-being.
  • Learn to help patients view films from a mindfulness perspective in which inspiring characters embody compassion as a means to resilient well-being for the purpose of renewing these qualities in patients’ lives.

Monday, August 8

  • “City Lights” (1931, 1’ and 27”, directed by Charles Chaplin)
  • Monday evening: Optional film (non-CME) “The Flowers of St. Francis” (1950, 1’ and 25”, directed by Roberto Rossellini and co-written by Federico Fellini)

Tuesday, August 9
“Roma” (2018, 2’ and 15”, directed by Alfonso Cuarón)

Wednesday, August 10 (session ends at 1:15 pm)
“Red Beard” (1965, 3’ and 5”, directed by Akira Kurosawa)

Thursday, August 11

  • “Won’t You Be My Neighbor” (2018, 1’ and 35”, directed by Morgan Neville)
  • Thursday evening: Optional film (non-CME) “The Last Dalai Lama?” (2016, 1’ and 22”, directed by Mickey Lemle)

Friday, August 12
“Bagdad Café” (1987, 1’ and 35”, directed by Percy Adlon)

Session 7 (2 Days) | August 8–9, 2022 | 8 a.m.-12:15 p.m.

Christina L. Wichman, DO
A Primer in Perinatal Mental Health

Dr. Christina Wichman is a Professor of Psychiatry and Obstetrics and Gynecology at the Medical College of Wisconsin and is Vice Chair for Education in MCW’s Psychiatry Department. She completed residency in Adult Psychiatry and fellowship in Consultation-Liaison Psychiatry at Mayo Clinic. Clinically, she created and directs a co-located perinatal psychiatric service, embedded within the Department of Obstetrics and Gynecology, and is the Director of Women’s Mental Health at the Medical College of Wisconsin. She is the Medical Director of The Periscope Project, a provider to perinatal psychiatrist teleconsultation service. Dr. Wichman’s research pursuits have been within the realm of women’s mental health; she has published and lectured extensively regionally and nationally.

Course Description

The field of perinatal (or reproductive psychiatry) has been ever-expanding in recent years. Extensive research has been conducted on the impact of psychiatric disorders in the perinatal period and their impact on fetus, neonate and child, as well as the parent. Expanding research has been completed in the areas of psychopharmacology in pregnancy and lactation. Unfortunately, while psychiatric disorders are the most common complication of the perinatal period, most providers, including mental health providers, do not feel comfortable with management during pregnancy and afterwards. This symposium will provide an overview of the assessment and management of common, as well as more complex psychiatric disorders in the perinatal period, including depression, anxiety, bipolar disorder, attention deficit disorder and opioid use disorder.

Learning Objective

Participants who engage in this education intervention will be able to:

  • Differentiate between perinatal mood and anxiety disorders.
  • List validated tools for screening of perinatal depressive and anxiety symptoms.
  • List the risks to the fetus/infant of antidepressant, anxiolytic, mood stabilizer, and stimulant exposure in utero and during lactation.
  • List indication of use of brexanolone.
  • Identify risks of untreated psychiatric disorders, including substance use disorders, in the perinatal period.

Monday, August 8

  • Introduction to field of perinatal mental health, including prevalence, etiology and types of psychiatric disorders seen in the perinatal period.
  • Review risks of untreated psychiatric disorders in pregnancy.
  • Review of validated screening tools for depression, anxiety and substance use disorders in the perinatal period.
  • Differentiation between baby blues, perinatal depression and postpartum depression and postpartum psychosis.
  • Review of psychopharmacology of antidepressant, anxiolytic and hypnotic use in pregnancy and lactation.
  • Case studies and discussion woven throughout didactic content.

Tuesday, August 9

  • Management of bipolar disorder in perinatal period.
  • Management of opioid use disorder in perinatal period.
  • Utilization of stimulant use in pregnancy.
  • Introduction of brexanolone and zuranolone as treatment options for postpartum depression.
  • Case studies and discussion woven throughout didactic content.
Session 8 (2 Days) | August 11–12, 2022 | 8 a.m.-12:15 p.m.

Art Walaszek, MD
Caring for our Aging Patients: Depression, Anxiety, and Dementia

Dr. Art Walaszek is a board-certified geriatric psychiatrist and Professor of Psychiatry at the University of Wisconsin School of Medicine and Public Health. Dr. Walaszek is Vice Chair for Education and Faculty Development in the Department of Psychiatry. He is past president of the American Association of Directors of Psychiatric Residency Training (AADPRT), and currently serves on the Psychiatry Review Committee of the Accreditation Council for Graduate Medical Education (ACGME). His research focuses on public health approaches to improving the care of people with dementia. Dr. Walaszek works with the Wisconsin Alzheimer’s Disease Research Center, where he is Co-Leader of the Outreach, Recruitment and Education Core, and with the Wisconsin Alzheimer’s Institute, where he leads the Public Health Pillar. He is the author of Behavioral and Psychological Symptoms of Dementia and the editor of Late-Life Depression and Anxiety, both from APA Publishing. Dr. Walaszek provides care to older adults with depression, anxiety, dementia and other mental health conditions, and teaches others to do the same.

Course Description

Depression and anxiety disorders threaten our ability to age successfully. Whereas sadness, grief and worry are core parts of being a human, depression and anxiety disorders are not inevitable. But they are emotionally painful, physically uncomfortable, disabling and potentially fatal. Suicide is a significant global health problem, especially among older adults, and depression contributes mightily to the risk of suicide. Thankfully, we can identify people with late-life depression and anxiety, we can diagnose them accurately, and we can offer treatment that works. In other words, people suffering from these conditions can find relief, maintain their independence, and lower their risk of dying due to suicide.

Around 6 million people in the United States are currently suffering from dementia. Over 90% of persons living with dementia experience behavioral and psychological symptoms of dementia (BPSD) over the course of their illness, including agitation, depression, apathy and psychosis. These symptoms profoundly affect quality of life, relationships with loved ones, personal safety, autonomy, dignity, and independence. BPSD sometimes arise unpredictably, with terrible timing, when a family is already struggling to address the cognitive and functional consequences of dementia. We will discuss how to comprehensively assess BPSD and then move on to evidence-based approaches to managing BPSD pharmacologically and non-pharmacologically. Our ultimate goal is that the burden of having dementia or caring for someone with dementia can be lifted, at least a little bit.

Learning Objective

Participants who engage in this education intervention will be able to:

  • Describe how to evaluate depression and anxiety among older adults.
  • Develop a treatment plan for depression and anxiety among older adults, incorporating the most recent evidence base.
  • Review how to evaluate behavioral and psychological symptoms of dementia (BPSD).
  • Discuss the elements of a plan to manage BPSD, including non-pharmacological interventions.

Thursday, August 11
Late-life depression & anxiety

Friday, August 12
Behavioral & psychological symptoms of dementia

Tuition and Refunds

Tuition for 5-day sessions is $675. Two-day sessions are $375. Tuition for graduate/medical students and resident physicians is $400 and $215, respectively, with a letter from the training director.

Tuition for 5-day sessions will be reduced to $630, and to $350 for 2-day sessions, if received by June 1, 2022.


Lodging in July and August is in great demand; it is crucial that you make reservations early. A block of suites has been set aside at the Landmark Resort. These suites will be held until June 17, 2022, or until they are filled. After that, the rooms are on a space available basis.

From its site on the bluff, the Landmark offers outstanding views of the waters of Green Bay with 294 units comprised of 1, 2, and 3 bedroom suites. Facilities include the Carrington Pub and Grill, 10 meeting and function rooms, 1 indoor and 3 outdoor pools, 2 tennis courts, whirlpools and steam rooms, and a fitness center and game room. The Landmark Resort is Door County’s largest and best full-service facility. As of May 2017, all suites at the Landmark have been renovated! Visit their website for photos and details.

The Landmark Resort
4929 Landmark Dr.
Egg Harbor, Wisconsin 54209
Reservations (800) 273-7877

Please indicate that you are attending the Summer Institute.

Make your reservation


Consistent with ACCME policy, faculty for all MCW continuing education programs must disclose all relevant financial relationships with commercial organizations. MCW has a mechanism in place to identify and resolve conflicts in advance of the DCSI.

Accreditation & Accreditation Statement

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit Statement

The Medical College of Wisconsin designates each week-long session of this live activity for a maximum of 15 AMA PRA Category 1 Credit TM and each two-day session for a maximum of 4 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. MCW designates each week-long session for up to 15 hours of participation and each two-day session for up to 8 hours of participation for continuing education for allied health professionals.

Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates each week-long session of this live activity for up to 15.0 hours of participation for continuing education for allied health professionals and each two-day session a maximum of 8.0 hours of participation for continuing education for allied health professionals.

Psychology CE Credit Statement
The Medical College of Wisconsin is approved by the American Psychological Association to sponsor continuing education for psychologists. The Medical College of Wisconsin maintains responsibility for this program and its content.

This activity contains content or processes that may be potentially stressful.

For more information contact:
Kiara Bond
MCW Department of Psychiatry
8701 Watertown Plank Rd.
Milwaukee, WI 53226

(414) 955-7250 | |


Please note that MCW accepts payment by Visa, MasterCard, and Discover.

Register via EthosCE

  • If you do not already have an EthosCE account, select Create Account in the upper right-hand corner and enter all of the required information.
  • You will need to access this account again to complete a course evaluation and print your CE certificate, so please make a note of your username and password.
  • The deadline for claiming credit is December 31, 2022, after which you will not be able to obtain your credits.

Register and Pay for a Session

Log in to your newly created or existing Ethos account, then select:

  1. Specialties
  2. Behavioral Health
  3. The 35th Annual Door County Summer Institute
  4. Select a session you wish to attend and add to cart
  5. Click Checkout to pay or Continue Shopping to add another session

Registration Fees

5-day sessions:

  • Before June 1, 2022: $630
  • After June 1, 2022: $675

2-day sessions:

  • Before June 1, 2022: $350
  • After June 1, 2022: $375

Medical/Graduate Students & Residents*

5-day sessions:

  • Before June 1, 2022: $350
  • After June 1, 2022: $400

2-day sessions:

  • Before June 1, 2022: $175
  • After June 1, 2022: $215

*Call (414) 955-7250 for coupon code

About Door County

About Door County

Door County, WI, is an area of captivating scenic beauty. From its steep limestone bluffs to the spacious sand beaches, the 250-mile shoreline is both dramatic and serene. Almost every kind of outdoor activity is available, as the area has four state parks and many local parks, beaches, hiking trails, and golf courses.

Past Brochures

Contact Information

Kiara Bond

(414) 955-7250 |


MCW Department of Psychiatry
8701 Watertown Plank Rd.
Milwaukee, WI 53226